Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

D Liebowitz, K Gottlieb, NS Kolhatkar… - The Lancet Infectious …, 2020 - thelancet.com
Background Influenza is an important public health problem and existing vaccines are not
completely protective. New vaccines that protect by alternative mechanisms are needed to …
被引用次数：88 相关文章

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

D Liebowitz, K Gottlieb, NS Kolhatkar… - The Lancet Infectious …, 2020 - thelancet.com
Background Influenza is an important public health problem and existing vaccines are not
completely protective. New vaccines that protect by alternative mechanisms are needed to …

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

D Liebowitz, K Gottlieb, NS Kolhatkar… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Influenza is an important public health problem and existing vaccines are not
completely protective. New vaccines that protect by alternative mechanisms are needed to …

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study.

D Liebowitz, K Gottlieb, NS Kolhatkar… - The Lancet. Infectious …, 2020 - europepmc.org
BACKGROUND: Influenza is an important public health problem and existing vaccines are
not completely protective. New vaccines that protect by alternative mechanisms are needed …

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study.

D Liebowitz, K Gottlieb, NS Kolhatkar, SJ Garg… - 2020 - cabidigitallibrary.org
Background: Influenza is an important public health problem and existing vaccines are not
completely protective. New vaccines that protect by alternative mechanisms are needed to …

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

D Liebowitz, K Gottlieb, NS Kolhatkar, SJ Garg… - The Lancet Infectious …, 2020 - Elsevier
Background Influenza is an important public health problem and existing vaccines are not
completely protective. New vaccines that protect by alternative mechanisms are needed to …

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

D Liebowitz, K Gottlieb, NS Kolhatkar, SJ Garg… - The Lancet Infectious …, 2020 - Elsevier
Background Influenza is an important public health problem and existing vaccines are not
completely protective. New vaccines that protect by alternative mechanisms are needed to …